Adaptimmune Therapeutics
ADAP
#9234
Rank
C$0.10 B
Marketcap
$0.38
Share price
4.45%
Change (1 day)
-75.64%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -$0.72

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.74. In 2022 the company made an earnings per share (EPS) of -$1.41 a decrease over its 2021 EPS that were of -$1.41.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.72-48.75%
2022-$1.41-0%
2021-$1.416.25%
2020-$1.33-27.27%
2019-$1.8329.41%
2018-$1.4120.09%
2017-$1.17-16.73%
2016-$1.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$9.94 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.30 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.45 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.39-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA